Yatharth Hospital and Trauma Care Services Limited (IN:YATHARTH)
:YATHARTH
Want to see IN:YATHARTH full AI Analyst Report?
Top Page
Yatharth Hospital and Trauma Care Services Limited
(YATHARTH)
Select Model
Select Model
Rating:63Neutral
Price Target:
₹873.00
▲(24.75% Upside)
Action:Reiterated
Date:05/26/26
The score is primarily supported by strong growth and solid profitability alongside improved leverage, but is held back by persistently negative and volatile free cash flow. Technically, the stock shows a generally positive trend with neutral momentum, while valuation is a meaningful headwind due to a high P/E and no dividend support.
Positive Factors
Strong revenue growth
Sustained top-line expansion (~36% revenue growth) reflects rising patient volumes and successful scaling of the hospital network. Over the next 2–6 months this durable demand trajectory supports capacity utilization, incremental operating leverage, and long-term revenue visibility independent of short-term market moves.
Negative Factors
Negative, volatile free cash flow
Despite positive operating cash in the latest year, persistent negative free cash flow in FY2025–FY2026 and historical volatility reduce durable financial flexibility. Continued negative FCF forces reliance on external funding for capex and expansion, raising refinancing and execution risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Sustained top-line expansion (~36% revenue growth) reflects rising patient volumes and successful scaling of the hospital network. Over the next 2–6 months this durable demand trajectory supports capacity utilization, incremental operating leverage, and long-term revenue visibility independent of short-term market moves.
Read all positive factors
Yatharth Hospital and Trauma Care Services Limited (YATHARTH) vs. iShares MSCI India ETF (INDA)
Market Cap
₹83.15B
Dividend YieldN/A
Average Volume (3M)28.98K
Price to Earnings (P/E)36.2
Beta (1Y)1.27
Revenue Growth36.20%
EPS Growth27.59%
CountryIN
Employees3,607
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)16.74
Shares Outstanding96,354,355
10 Day Avg. Volume38,534
30 Day Avg. Volume28,985
Financial Highlights & Ratios
PEG Ratio1.43
Price to Book (P/B)3.34
Price to Sales (P/S)4.93
P/FCF Ratio-62.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27.87
Revenue Forecast (FY)₹16.14B
Yatharth Hospital and Trauma Care Services Limited Business Overview & Revenue Model
Company Description
Yatharth Hospital & Trauma Care Services Limited owns and operates super-specialty hospitals in Delhi and Madhya Pradesh. The company offers services in the areas of gynecology; gastroenterology; pulmonology; pediatric; nephrology and urology; car...
How the Company Makes Money
YATHARTH primarily makes money by delivering hospital-based healthcare services and charging patients (or their payors) for clinical care and related hospital services. Key revenue streams typically include: (1) Inpatient services: room/bed charge...
Yatharth Hospital and Trauma Care Services Limited Financial Statement Overview
Summary
Income Statement
76
Positive
Balance Sheet
71
Positive
Cash Flow
42
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.88B | 12.07B | 8.80B | 6.71B | 5.20B | 4.01B |
| Gross Profit | 6.73B | 6.50B | 5.39B | 5.37B | 4.27B | 3.20B |
| EBITDA | 2.69B | 2.92B | 2.36B | 1.96B | 1.37B | 1.13B |
| Net Income | 1.52B | 1.75B | 1.31B | 1.14B | 657.68M | 441.62M |
Balance Sheet | ||||||
| Total Assets | 18.56B | 22.82B | 17.31B | 10.19B | 4.86B | 4.26B |
| Cash, Cash Equivalents and Short-Term Investments | 2.83B | 2.63B | 5.15B | 2.39B | 382.36M | 120.31M |
| Total Debt | 262.33M | 2.64B | 115.86M | 846.47M | 2.67B | 2.64B |
| Total Liabilities | 1.36B | 4.74B | 940.45M | 1.45B | 3.03B | 3.09B |
| Stockholders Equity | 16.89B | 17.81B | 16.05B | 8.74B | 1.83B | 1.17B |
Cash Flow | ||||||
| Free Cash Flow | -1.49B | -956.83M | -1.61B | -964.43M | 439.70M | 468.01M |
| Operating Cash Flow | 485.14M | 2.21B | 1.50B | -30.78M | 637.84M | 599.35M |
| Investing Cash Flow | -2.51B | -6.17B | -4.20B | -2.26B | -203.10M | -521.75M |
| Financing Cash Flow | 142.57M | 2.56B | 5.19B | 3.04B | -177.48M | -11.24M |
Yatharth Hospital and Trauma Care Services Limited Technical Analysis
Neutral
699.80
Price Trends
748.47
Positive
701.51
Positive
725.36
Positive
Market Momentum
23.19
Positive
52.65
Neutral
43.81
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:YATHARTH, the sentiment is Neutral. The current price of 699.8 is below the 20-day moving average (MA) of 828.01, below the 50-day MA of 748.47, and below the 200-day MA of 725.36, indicating a neutral trend. The MACD of 23.19 indicates Positive momentum. The RSI at 52.65 is Neutral, neither overbought nor oversold. The STOCH value of 43.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:YATHARTH.
Yatharth Hospital and Trauma Care Services Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹32.92B | 20.46 | ― | 0.96% | 9.30% | 14.06% | |
63 Neutral | ₹83.15B | 36.23 | ― | ― | 36.20% | 27.59% | |
63 Neutral | ₹391.85B | 88.98 | ― | 0.84% | 12.20% | -93.03% | |
62 Neutral | ₹97.61B | 875.33 | ― | ― | 16.15% | -67.50% | |
56 Neutral | ₹305.73B | 103.07 | ― | ― | 28.65% | -37.24% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | ₹18.42B | 310.39 | ― | 0.59% | 4.93% | -75.50% |
* Healthcare Sector Average
IN:YATHARTH
Yatharth Hospital and Trauma Care Services Limited
820.10
306.60
59.71%
IN:ASTERDM
Aster DM Healthcare Ltd.
746.15
198.11
36.15%
IN:HCG
HealthCare Global Enterprises Ltd.
656.70
126.38
23.83%
IN:INDRAMEDCO
Indraprastha Medical Corporation Limited
364.60
-72.82
-16.65%
IN:KIMS
Krishna Institute of Medical Sciences Limited
757.15
102.25
15.61%
IN:SHALBY
Shalby Ltd.
173.55
-26.20
-13.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.